W. Sirirungsri, “Serious Adverse Events Attributed to Nevirapine Regimens for Postexponsure Prophylaxis After HIV Exposures-Worldwide, 1997-2000”, J Assoc Med Sci, vol. 34, no. 2, p. 131, Feb. 2015.